Early study suggests Pfizer vaccine effective against coronavirus mutations
- A study by
Pfizerand researchers at the University of Texas Medical Branch indicates the company's COVID-19 vaccineis effective against mutations of the coronavirus.
- The study has not yet been peer-reviewed.
- "So we've now tested 16 different mutations, and none of them have really had any significant impact. That's the good news," Phil Dormitzer, a scientist at Pfizer, said Thursday.
- "That doesn't mean that the 17th won't," he added.
As Reuters reported, the study, by researchers at Pfizer and the University of Texas Medical Branch, suggests the vaccine will not need to be tweaked in order to work against a seemingly more contagious variant of the coronavirus that arose in the UK.The British variant, known as B117, was recently detected in the United States among people who had not traveled to the UK, indicating community spread.
"So we've now tested 16 different mutations, and none of them have really had any significant impact. That's the good news," Phil Dormitzer, a scientist at Pfizer, said Thursday. "That doesn't mean that the 17th won't."Have a news tip? Email this reporter: email@example.com
- Chris Gayle appears four times in the top 10 list of most sixes hit in an IPL match
- Up-close and not so personal with Munnar’s pit vipers, gliding frogs and more
- Haryana government extends lockdown in the state till May 24
- UK's Cairn Energy identifies $70 billion Indian assets for seizing to recover amount due from government
- States to receive nearly 51 lakh COVID-19 vaccine doses in next three days, says Union Health Ministry